# Oxandrolone Multiligament Knee

> **NCT05893069** · PHASE4 · SUSPENDED · sponsor: **George F. Hatch** · enrollment: 60 (estimated)

## Conditions studied

- Ligament Tear Knee

## Interventions

- **DRUG:** Oxandrolone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05893069
- **Lead sponsor:** George F. Hatch
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2023-07-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Why stopped:** FDA withdrew approval of the study product
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05893069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05893069, "Oxandrolone Multiligament Knee". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05893069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*